Cardiac resynchronization therapy: redefining the role of device therapy in heart failure

Karthik Viswanathan1, Justin Ghosh, Gerry C Kaye

  • 1Specialist Registrar in Cardiology, Castle Hill Hospital, Department of Cardiology, Kingston-upon-Hull, HU16 5JQ, UK. drkarthikv@hotmail.com.

Insights

Cardiac dyssynchrony impairs heart efficiency. Cardiac resynchronization therapy (CRT) effectively treats this, improving outcomes for heart failure patients.

Area of Science:

  • Cardiology
  • Biomedical Engineering

Background:

  • Cardiac dyssynchrony, a known factor in reduced cardiac efficiency for decades, gained clinical attention with advanced therapies.
  • Limited awareness existed despite understanding its impact on cardiac function.

Purpose of the Study:

  • To review the complex nature of cardiac dyssynchrony.
  • To discuss the epidemiology, effects, and patient selection for cardiac resynchronization therapy (CRT).
  • To cover practical aspects and future questions regarding CRT.

Main Methods:

  • Literature review of cardiac dyssynchrony and cardiac resynchronization therapy.
  • Analysis of clinical trial data and technological advancements in CRT devices.
  • Synthesis of information on patient selection, implantation, and monitoring.

Main Results:

  • Cardiac resynchronization therapy (CRT) has become a widespread treatment.
  • Significant advances in CRT technology and large-scale trials have validated its use.
  • CRT offers effective therapy for patients with specific cardiac conditions.

Conclusions:

  • Cardiac dyssynchrony is a significant factor in cardiac inefficiency.
  • Cardiac resynchronization therapy (CRT) is a highly effective treatment option.
  • Further research is needed to address remaining questions in CRT.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...